Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2016

Main Data: 31/12 Year 2016
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions / Euro
– total revenues 1,310.85
– industrial gross profit 480.59
– total operating cost 339.25
– operating profit 141.34
– net financial income 6.28
– profit attributable to equity holders of the parent 93.54

 

Consolidated balance sheet Millions / Euro
– working capital 3.42
– non-current assets 446.96
– provision for severance indemnities and other provisions

-80.26

– net debt -99.94
– equity pertaining to the group and minority interests 270.18

 

Other information Millions / Euro
– depreciation, amortization and impairment 39.55
– R & D costs 48.15

 

  Euro
Dividend per share 1.40

 

  No.
Employees 5,109

 

  Euro
Share capital 20,415,200

 

Main Data: 30/06 Year 2016
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 572.2
– gross industrial income  214.7
– total operating cost 169.9
– operating profit 44.8
– net financial income 13.1
– profit attributable to equity holders of the parent 39.4

 

Consolidated balance sheet Millions/Euro
– working capital 41.4
– non-current assets 434.9
– provision for severance indemnities and other provisions -80.8
– net debt -188.9
– equity pertaining to the group and minority interests 206.6

 

Other information Millions/Euro
– depreciation, amortization and impairment 18.3
– R & D costs 23.6

 

  No.
Employees 4,962

 

  Euro
Share capital 20,415,200

 

Net Sales By Sector: Year 2016
  Millions/Euro  
tea, food & other 757.42 57.8%
pharmaceutical 553.43 42.2%
Total 1,310.85 100.0%

 

Net Sales by Country: Year 2016
  Millions/Euro  
E.U. (excluding Italy) 395.45 30.2%
Other European countries 97.33 7.4%
North America 218.69 16.7%
Asia & Middle East 294.65 22.5%
Other countries 128.63 9.8%
Total exports 1,134.75 86.6%
Italy 176.10 13.4%
Total 1,310.85 100.0%